> Despite being described as a “cabal,” the amyloid camp was neither organized nor nefarious. Those who championed the amyloid hypothesis truly believed it, and thought that focusing money and attention on it rather than competing ideas was the surest way to an effective drug.
This discrepancy indicates part of the problem: the investigators narrowing the search for causes honestly believe in what they're doing.
The NIH review panelists really believe they're safeguarding the NIH budget, and the Pharma execs really believe they're wisely allocating their R&D budget.
> Despite being described as a “cabal,” the amyloid camp was neither organized nor nefarious. Those who championed the amyloid hypothesis truly believed it, and thought that focusing money and attention on it rather than competing ideas was the surest way to an effective drug.
This discrepancy indicates part of the problem: the investigators narrowing the search for causes honestly believe in what they're doing.
The NIH review panelists really believe they're safeguarding the NIH budget, and the Pharma execs really believe they're wisely allocating their R&D budget.